LONGITUDINAL NATURAL HISTORY OF PATIENTS WITH TYPE I/II HEREDITARY ANGIOEDEMA: ICATIBANT OUTCOME SURVEY DATA

被引：0
|
作者：
Maurer, M.
Caballero, T.
Aberer, W.
Zanichelli, A.
Bouillet, L.
Bygum, A.
Grumach, A.
Pommie, C.
Andresen, I.
Longhurst, H.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2017年 / 119卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P164
引用
收藏
页码：S42 / S43
页数：2
相关论文
共 50 条
  • [31] Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the Icatibant Outcome Survey
    Aberer, Werner
    Maurer, Marcus
    Bouillet, Laurence
    Zanichelli, Andrea
    Caballero, Teresa
    Longhurst, Hilary J.
    Perrin, Amandine
    Andresen, Irmgard
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2017, 13
  • [32] Hereditary angioedema presents in childhood but is diagnosed in adulthood findings from the Icatibant outcome survey
    Longhurst, H.
    Aberer, W.
    Bouillet, L.
    Caballero, T.
    Bygum, A.
    Grumach, A. S.
    Fabien, V
    Andresen, I
    Zanichelli, A.
    Maurer, M.
    ALLERGY, 2016, 71 : 243 - 243
  • [33] The Icatibant Outcome Survey: experience of hereditary angioedema management from four European countries
    Caballero, T.
    Aberer, W.
    Longhurst, H.
    Maurer, M.
    Zanichelli, A.
    Fabien, V
    Bouillet, L.
    ALLERGY, 2014, 69 : 54 - 54
  • [34] The Icatibant Outcome Survey: experience of hereditary angioedema management from six European countries
    Caballero, T.
    Aberer, W.
    Longhurst, H. J.
    Maurer, M.
    Zanichelli, A.
    Perrin, A.
    Bouillet, L.
    Andresen, I.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (07) : 1214 - 1222
  • [35] Short-term prophylactic treatment of hereditary angioedema type II with icatibant
    Clemens, P.
    ALLERGY, 2011, 66 : 429 - 429
  • [36] Self-administration of icatibant in acute attacks of Type I hereditary angioedema: A case report and review of hereditary angioedema
    Piras, Viviana
    Alves, Francisca
    Goncalo, Margarida
    DERMATOLOGIC THERAPY, 2019, 32 (06)
  • [37] The Icatibant Outcome Survey: Characterizing Breakthrough Hereditary Angioedema Attacks In Patients Receiving Long-Term Prophylaxis
    Aberer, Werner
    Maurer, Marcus
    Bouillet, Laurence
    Perrin, Amandine
    Zanichelli, Andrea
    Caballero, Teresa
    Longhurst, Hilary
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : AB35 - AB35
  • [38] Efficacy of Icatibant is Consistent by Attack Frequency and Baseline Severity in the Treatment of Type I and II Hereditary Angioedema (HAE) Attacks
    Reshef, A.
    Levy, R.
    Craig, T.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB218 - AB218
  • [39] An evidence-based review of the potential role of icatibant in the treatment of acute attacks in hereditary angioedema type I and II
    Floccard, Bernard
    Hautin, Etienne
    Bouillet, Laurence
    Coppere, Brigitte
    Allaouchiche, Bernard
    CORE EVIDENCE, 2012, 7 : 105 - 114
  • [40] Real-World Outcomes In Hereditary Angioedema: Experience From The Icatibant Outcome Survey In The United Kingdom
    Longhurst, Hilary
    Dempster, John
    Lorenzo, Lorena
    Buckland, Matthew
    Grigoriadou, Sofia
    Fabien, Vincent
    Bangs, Catherine
    Helbert, Matthew
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2015, 182 : 10 - 11
12345